Gemcitabine in the treatment of relapsed and refractory Hodgkin's disease

被引：0
|
作者：
Milosevic, V. [1 ]
Petrovic, M. [1 ]
Mihaljevic, B. [1 ]
Jankovic, S. [1 ]
Nedeljkov, R. Jancic [1 ]
Boskovic, D. [1 ]
机构：
[1] Inst Hematol, Belgrade, Serbia
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1239
引用
收藏
页码：451 / 451
页数：1
相关论文
共 50 条
  • [1] Gemcitabine in the treatment of relapsed and refractory Hodgkin's disease
    Aurer, I
    Radman, I
    Nemet, D
    Zupancic-Salek, S
    Bogdanic, V
    Mrsic, M
    Sertic, D
    Labar, B
    ONKOLOGIE, 2005, 28 (11): : 567 - 571
  • [2] Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphoma
    Mendler, J. H.
    Kelly, J.
    Voci, S.
    Marquis, D.
    Rich, L.
    Rossi, R. M.
    Bernstein, S. H.
    Jordan, C. T.
    Liesveld, J.
    Fisher, R. I.
    Friedberg, J. W.
    ANNALS OF ONCOLOGY, 2008, 19 (10) : 1759 - 1764
  • [3] Gemcitabine as a single agent in the treatment of relapsed or refractory Hodgkin's and Non Hodgkin's lymphoma.
    Jajeh, A
    Hadad, L
    Godo, C
    Nukala, S
    BLOOD, 2001, 98 (11) : 242B - 243B
  • [4] Gemcitabine combined with oxaliplatin in the treatment of relapsed or refractory Hodgkin lymphoma
    Coliat, P.
    El Aatmani, A.
    Berceanu, A.
    Leveque, D.
    Herbrecht, R.
    Beretz, L.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (02) : 459 - 459
  • [5] Gemcitabine is active in relapsed Hodgkin's disease
    Lucas, JB
    Horwitz, SM
    Horning, SJ
    Sayegh, A
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) : 2627 - 2628
  • [6] Gemcitabine as single agent in the treatment of relapsed and refractory Hodgkin's and non-Hodgkin lymphoma.
    Jajeh, A
    Hadad, L
    Zalzaleh, G
    Ruestow, P
    BLOOD, 2003, 102 (11) : 285B - 285B
  • [7] Activity of vinorelbine/gemcitabine in relapsed/refractory Hodgkin's and non-Hodgkin's lymphoma
    不详
    CLINICAL LYMPHOMA, 2003, 3 (04): : 207 - 208
  • [8] Preliminary experience with paclitaxel for the treatment of relapsed and refractory Hodgkin's disease
    Younes, A
    Cabanillas, F
    McLaughlin, PW
    Hagemeister, FB
    Farber, C
    Sarris, A
    Pate, O
    Myers, J
    Portlock, C
    ANNALS OF ONCOLOGY, 1996, 7 (10) : 1083 - 1085
  • [9] GEMCITABINE (GEMZAR) AS A SALVAGE THERAPY AT RELAPSED AND REFRACTORY HODGKIN'S LYMPHOMA
    Violeta, V.
    Jankovic, S.
    Andjelic, B.
    Bogunovic, M.
    Petrovic, M.
    Mihaljevic, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 637 - 637
  • [10] Gemcitabine as a single agent in the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma
    Fosså, A
    Santoro, A
    Hiddemann, W
    Truemper, L
    Niederle, N
    Buksmaui, S
    Bonadonna, G
    Seeber, S
    Nowrousian, MR
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) : 3786 - 3792
12345